Alexander M. Eggermont
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 375 publications
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 16, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2026
Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: February 17, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 13, 2026
Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.
Journal: Molecular oncology
Published: October 31, 2025
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 31, 2025
An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC).
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 06, 2025
The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.
Journal: Ecancermedicalscience
Published: August 25, 2025
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.
Journal: Nature
Published: August 17, 2025
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.
Journal: Nature communications
Published: July 24, 2025
Approaches to overcome the current treatment plateau in immunotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 01, 2025
Last Updated: 09/26/2026